Skip to Content

MD Anderson Events

CPC Grand Rounds - Biomarker Based Personalized Cancer Risk Assessment and Early Detection

CPC Grand Rounds - Biomarker Based Personalized Cancer Risk Assessment and Early Detection

The Division of Cancer Prevention and Population Sciences, Cancer Prevention & Control Grand Rounds presents Dr. Samir Hanash from Clinical Cancer Prevention October 13, 2017.

Date: 10/13/17, 12pm to 1pm
Time: 10/13/17, 12pm to 1pm
Location: Mays Clinic, ACB, 1.2325ABC First Floor
Format: Grand Rounds
CME: 1 CME & 1 CHES/MCHES Credit
Speaker: Dr. Samir Hanash
Speaker Bio: Dr. Hanash was recruited to join MD Anderson in July 2012 to lead the Red and Charline Mc Combs Institute for Cancer Early Detection and Treatment of Cancer. He was previously Program Head for Molecular Diagnostics at the Fred Hutchinson Cancer Research Center in Seattle, Washington. Dr. Hanash’ s interests and expertise focus on the development and application of integrated approaches for the molecular profiling of cancer, with particular emphasis on the application of proteomics technologies for the development of blood based markers to identify subjects at increased risk of developing cancer and markers for early detection of cancer and for tumor classification. The work involves sorting through tens of thousands of protein forms in the blood most of which occur at exceedingly low abundance to identify those that are most relevant to particular cancer types. Dr. Hanash has been a program principal investigator for several multi-investigator projects aimed at discovery and validation of cancer markers. He has led a consortium of investigators working on molecular profiling of lung cancer to identify molecular risk factors for developing lung cancer among smokers as well never smokers that can be used to develop a blood test for lung cancer risk. Another goal is to develop blood based markers for the early detection of lung cancer. He has also led similar efforts to identify markers for the early detection of other cancers notably breast, ovarian, pancreas and colon.
Contact: Jennifer Tijerina - (832) 750-1629 - jmcastillo1@mdanderson.org